SCHEMBL23071471

SCHEMBL23071471

[c]1cccc2ncc3c4ccccc4sc3c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.38
EGLN1 Q9GZT9 1/20 0.37
LIMK1 P53667 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
MAPT P10636 3/20 0.35
EGFR P00533 2/20 0.33
PDE10A Q9Y233 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RAB9A P51151 4/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ILK Q13418 1/20 0.31
HSD17B10 Q99714 3/20 0.31
ALDH1A1 P00352 3/20 0.31
TP53 P04637 2/20 0.31
NPC1 O15118 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23071515 0.79 GPR3 (0.38) GPR3MAPTPDE10AKDM4ERAB9A
SCHEMBL22344979 0.73 GPR3 (0.42) GPR3LIMK1CDK5CDK5R1MAPT
SCHEMBL4408 0.70 KDM4E (0.57) GPR3MAPTEGFRPDE10AKDM4E
SCHEMBL5007 0.69 GPR3 (0.54) GPR3LIMK1MAPTKDM4EL3MBTL1
SCHEMBL26597 0.67 KDM4E (0.57) GPR3MAPTEGFRPDE10AKDM4E
SCHEMBL18859578 0.67 LIMK1 (0.42) GPR3EGLN1LIMK1MAPTEGFR
SCHEMBL23071488 0.67 SMN1; SMN2 (0.40) EGLN1LIMK1MAPTEGFRKDM4E
SCHEMBL18859575 0.66 LIMK1 (0.39) GPR3EGLN1LIMK1CDK5CDK5R1
SCHEMBL26087645 0.66 GPR3 (0.45) GPR3LIMK1CDK5CDK5R1MAPT
SCHEMBL2514608 0.66 KDM4E (0.50) GPR3MAPTKDM4ERAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-14 US disclosed
WO-2021045460-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 GPR3 2567/4885EGLN1 2360/4885LIMK1 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.